Inovio is a Pennsylvania-based biotechnology company that researches, develops, and commercializes synthetic vaccines and immune therapies for the treatment of cancer.Read more
Inovio's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 86.3M. Over the last four quarters, Inovio's revenue has decreased by 94.8%. Specifically, in Q3 2021's revenue was $ < 1M; in Q2 2021, it was $ < 1M; in Q1 2021, it was $ < 1M; in Q4 2020, Inovio's revenue was $5.6M.
660 West Germantown Pike Suite 110
Plymouth Meeting, Pennsylvania19462
1-267-440-4200Driving Directions »